CLINICAL_TRIALS
trial_result
· 2017-02-15
Clinical Trial Update: BAX 326 Surgery Study in Hemophilia B Patients [Phase 3]
Summary
A Phase 3 clinical trial update for BAX 326 (FVIII) in Hemophilia B has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Hemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2017-02-15